Gene · 2030
Papers2,306
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,306
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel approach to overcome drug resistance in acute myeloid leukemia. | Haematologica | 2023 | 37165841 | PubTator, text mining | PubMed |
| Profiles of Independent-Comorbidity Groups in Senior COVID-19 Patients Reveal Low Fatality Associated with Standard Care and Low-Dose Hydroxychloroquine over Antivirals. | J Multidiscip Healthc | 2023 | 37153358 | PubTator, text mining | PubMed |
| Parkinson's disease therapy: what lies ahead? | J Neural Transm (Vienna) | 2023 | 37147404 | PubTator, text mining | PubMed |
| Hypoxia-inducible factor orchestrates adenosine metabolism to promote liver cancer development. | Sci Adv | 2023 | 37146141 | PubTator, text mining | PubMed |
| Neural Stem Cells as Carriers of Nucleoside-Conjugated Nanogels: A New Approach toward Cell-Mediated Delivery. | ACS Appl Mater Interfaces | 2023 | 37127284 | PubTator, text mining | PubMed |
| Increased ENT2 expression and its association with altered purine metabolism in cell lines derived from different stages of colorectal cancer. | Exp Ther Med | 2023 | 37123217 | PubTator, text mining | PubMed |
| Altered Glycosylation in Progression and Management of Bladder Cancer. | Molecules | 2023 | 37110670 | PubTator, text mining | PubMed |
| A Novel Gemcitabine-Resistant Gallbladder Cancer Model Provides Insights into Molecular Changes Occurring during Acquired Resistance. | Int J Mol Sci | 2023 | 37108401 | PubTator, text mining | PubMed |
| Characterization and treatment of gemcitabine- and cisplatin-resistant bladder cancer cells with a pan-RAS inhibitor. | FEBS Open Bio | 2023 | 37079001 | PubTator, text mining | PubMed |
| LIF Inhibits Proliferation of Esophageal Squamous Carcinoma Cells by Radiation Mediated Through JAK-STAT Signaling Pathway. | J Cancer | 2023 | 37057285 | PubTator, text mining | PubMed |
| Diastereoselective Synthesis of (-)-6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinoline-1-carboxylic Acid via Morpholinone Derivatives. | Molecules | 2023 | 37049962 | PubTator, text mining | PubMed |
| Distal Flow Diversion with Anti-Thrombotically Coated and Bare Metal Low-Profile Flow Diverters-A Comparison. | J Clin Med | 2023 | 37048781 | PubTator, text mining | PubMed |
| High-Multiplex Aptamer-Based Serum Proteomics to Identify Candidate Serum Biomarkers of Oral Squamous Cell Carcinoma. | Cancers (Basel) | 2023 | 37046731 | PubTator, text mining | PubMed |
| Transporter Inhibition Profile for the Antivirals Tilorone, Quinacrine and Pyronaridine. | ACS Omega | 2023 | 37033868 | PubTator, text mining | PubMed |
| Paxlovid (Nirmatrelvir/Ritonavir): A new approach to Covid-19 therapy? | Biomed Pharmacother | 2023 | 37018987 | PubTator, text mining | PubMed |
| Purinergic Tuning of the Tripartite Neuromuscular Synapse. | Mol Neurobiol | 2023 | 37016047 | PubTator, text mining | PubMed |
| Serum Amyloid a Predicts Prognosis and Chemotherapy Efficacy in Patients with Advanced Pancreatic Cancer. | J Inflamm Res | 2023 | 36998322 | PubTator, text mining | PubMed |
| The adenosine hypothesis of schizophrenia into its third decade: From neurochemical imbalance to early life etiological risks. | Front Cell Neurosci | 2023 | 36998267 | PubTator, text mining | PubMed |
| Neuronal activity-induced, equilibrative nucleoside transporter-dependent, somatodendritic adenosine release revealed by a GRAB sensor. | Proc Natl Acad Sci U S A | 2023 | 36996110 | PubTator, text mining | PubMed |
| Regulation of Hypoxic-Adenosinergic Signaling by Estrogen: Implications for Microvascular Injury. | Pharmaceuticals (Basel) | 2023 | 36986520 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2030/papers?page=12